ɬÀï·¬

Award

Ejsing’s mass spec work
considered ‘essential
for further progress in the field’

He won the ɬÀï·¬ Walter A. Shaw Young Investigator Award in Lipid Research
Preethi Chander
By Preethi Chander
March 1, 2016

, associate professor at the University of Southern Denmark, is the recipient of the 2016  from the ɬÀï·¬. The award recognizes outstanding research contributions in the area of lipids by a young investigator who is an assistant professor (or equivalent) and has had no more than 10 years of experience since receiving a Ph.D. or MD.

Ejsing-Christer-235x293.jpg
“I am truly honored and humbled to receive this year’s Walter Shaw Young Investigator Award. I am very grateful to my colleagues for the nomination. This award would not have been possible without the support of great mentors and contributions from colleagues, students and our funding agencies.” — Christer S. Ejsing

Ejsing’s research focuses on the development and application of lipidomics technology that provide molecular insights into how lipid metabolism is regulated on a global scale. He successfully has applied shotgun mass spectrometry methods to extensively characterize the yeast lipidome — the first such analysis in a eukaryotic cell. Using this technique, Ejsing and collaborators also were able to describe lipid sorting during vesicle biogenesis in living cells. This is a feat that previously had been impossible with existing technologies.

On the experimental side, Ejsing has developed a new surface sampling method that streamlines lipid extraction for tissue imaging by mass spectrometry. On the computational front, he has created an open-source software platform, ALEX, to streamline data processing to extract quantitative lipid data from mass spectrometry data. In his letter supporting Ejsing's nomination for the award, at the Max Planck Institute talks about Ejsing’s latest quantitative proteolipidomics work on regulation of lipid homeostasis during physiological adaptations. Simons describes the work as “a truly impressive advance (that) will be essential for further progress in the field.”

After an early education in Denmark, Ejsing went on to do his Ph.D. and postdoctoral training at the Max Planck Institute in Dresden, Germany. There he developed innovative experimental and computational tools to harness the analytic power of a new generation of high resolution mass spectrometers for lipidomics. Since 2009, Ejsing has continued his pioneering work in lipidomics at his own independent laboratory in Denmark. He is also the founding member of the Danish Lipid Research Society and serves on the editorial board of the journal Scientific Data.

In his nomination letter, at the Texas A&M Health Science Center said, “Christer Ejsing is simply a winner — he is driven, he has exactingly high standards, and he is a ‘hard-core’ analytical biochemist. In my view, he is at the very top of the young investigator cohort involved in studying lipidomics and is already a pioneer in that field.”  of the Howard Hughes Medical Institute and Harvard University is a former Shaw award recipient who also supported Ejsing’s nomination and describes him as “a humble and friendly colleague … always helpful,” who has “the highest standard for his work.”

Watch Ejsing's award lecture, “Functional lipidomics: from lipid timelines to regulation of metabolic networks,” below.

Credit
 

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Preethi Chander
Preethi Chander

Preethi Chander did her Ph.D. in Biochemistry and Molecular Biology and her postdoctoral work in eye and vision research. She is interested in science policy and communications.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in People

People highlights or most popular articles

Before we’ve lost what we can’t rebuild: Hope for prion disease
Feature

Before we’ve lost what we can’t rebuild: Hope for prion disease

July 15, 2025

Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal — and just getting started.

ASBMB members recognized as Allen investigators
Member News

ASBMB members recognized as Allen investigators

July 14, 2025

Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.

AI can be an asset, ASBMB educators say
Advice

AI can be an asset, ASBMB educators say

July 9, 2025

Pedagogy experts share how they use artificial intelligence to save time, increase accessibility and prepare students for a changing world.

ASBMB undergraduate education programs foster tomorrow’s scientific minds
Feature

ASBMB undergraduate education programs foster tomorrow’s scientific minds

July 8, 2025

Learn how the society empowers educators and the next generation of scientists through community as well as accreditation and professional development programs that support evidence-based teaching and inclusive pedagogy.

Honors for Gagna and Sundquist
Member News

Honors for Gagna and Sundquist

July 7, 2025

Claude Gagna is being honored for the diagnostic tool he developed that uses AI to streamline diagnostics. Wesley Sundquist is being honored for his role in finding that HIV’s capsid was a target for treatment.

Gaze into the proteomics crystal ball
In-person Conference

Gaze into the proteomics crystal ball

July 1, 2025

The 15th International Symposium on Proteomics in the Life Sciences symposium will be held August 17–21 in Cambridge, Massachusetts.